Management of hip fractures during the COVID-19 pandemic at a high-volume hip fracture unit in the United Kingdom.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 32665751.
- Also identified by DOI 10.1016/j.jor.2020.06.018 and PMC identifier 7330585.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This study aimed to compare the treatment pathway and 30-day outcomes of hip fracture patients admitted during the COVID-19 pandemic with the pre-pandemic period. Three periods were retrospectively analysed: period C = 23/03/2020-11/05/2020, period A = 23/03/2018-11/05/2018, period B = 23/03/2019-11/05/2019. No statistically significant differences in time to surgery, type of treatment, complications, and mortality rates were noted. A significant reduction (p = 0.021) in the time to orthogeriatric assessment and length of inpatient stay (p < 0.001) was found in period C. Institutional adaptions to facilitate prompt treatment in hip fractures during the pandemic resulted in favourable outcomes.
Anatomy
- hip